BridgeBio Pharma, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 2CL.F | IONS | ALNY | BMRN | ROIV | GPCR | |
|---|---|---|---|---|---|---|
| Market cap | 11.91B | 7.31B | 30.35B | 10.71B | 26.39B | 1.54B |
| P/E (TTM) | — | — | 38.2 | 149.6 | — | — |
| Forward P/E | -17.0 | -38.3 | 18.4 | 8.7 | -21.3 | -10.2 |
| Price/book | -5.3 | 16.6 | 22.4 | 1.7 | 6.2 | 1.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +12.62% | −40.98% | −52.16% | +4.23% | +95.82% | −27.12% |
| Today | +0.54% | +1.24% | −0.38% | −0.72% | +1.36% | +2.13% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 2CL.F news ›Analysts Are Bullish on These Healthcare Stocks: Mediwound (MDWD), BridgeBio Pharma (BBIO)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mediwound (MDWD), BridgeBio Pharma (BBIO) and Tandem Diabetes Care (TNDM) with bullish sentiments. In a report released today, Josh Jennings…
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
The Manila Times PALO ALTO, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio” or the "Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com12
-
markets.businessinsider.com4
-
gurufocus.com3
-
manilatimes.net1
-
mugglehead.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 26 articles, not a forecast.